Latest Insider Trading
Filed: 2026-04-30
Key Insights
- William E. Martin III, President of Multiomics division, acquired 17,790 restricted stock units at $24.24 per share on 04/28/2026, representing a meaningful equity grant valued at approximately $431,000.
- The RSUs vest over three years in equal 33% tranches (April 2027, 2028, and 2029), indicating a long-term retention incentive structure aligned with multi-year performance objectives.
- This is an equity grant rather than open market purchase, suggesting the company is using stock-based compensation to retain executive talent in the Multiomics business unit.
- The filing shows no existing beneficial ownership balance disclosed, indicating this may be a new position or first-time equity grant for this officer.